Paragraph: Antimicrobial susceptibility testing refers to tests that determine the vulnerability of a pathogen to various antibiotics, antifungals, or antimicrobial agents. It is important for effective treatment of infections and helps prevent development of antimicrobial resistance by ensuring appropriate treatment. Antimicrobial susceptibility tests are widely used in hospitals, diagnostic laboratories, and research institutes to determine suitable treatment options for patients suffering from various bacterial or fungal infections like pneumonia, tuberculosis, and UTIs.

The global antimicrobial susceptibility testing market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
One of the primary drivers contributing to the growth of the antimicrobial susceptibility testing market is the increasing prevalence of infectious diseases globally. According to the World Health Organization (WHO), each year there are an estimated 1.5 million annual deaths worldwide due to antimicrobial resistance. Higher antibiotic resistance levels have been reported across many countries, especially among common infections like urine, bloodstream, and pneumonia. This has necessitated greater use of antimicrobial susceptibility testing for selecting effective treatment. Moreover, increased R&D activities and new product launches by market players for automated systems, rapid susceptibility testing kits, and advanced diagnostic methods are also fueling growth of this market. However, high instrumentation and maintenance costs associated with antimicrobial susceptibility testing can hamper market expansion to some extent.

SWOT Analysis

Strength: Antimicrobial Susceptibility Testing help determine the most effective antibiotic for treating bacterial infections in three easy steps - obtaining a sample, isolating any bacteria, and testing antibiotic effectiveness. This streamlines and expedites treatment. Automated systems for Antimicrobial Susceptibility Testing have greatly reduced testing times, with some systems providing results in as little as six hours. This faster identification of the most effective antibiotic allows physicians to begin optimal treatment sooner.

Weakness: Antimicrobial Susceptibility Testing requires specialized equipment, experienced technicians, and involves multiple manual steps of preparing and reading the tests. This makes the process complex and laborsome. The manual nature also leaves room for human errors. Lack of standardization across labs results in inconsistent susceptibility results for the same isolate.

Opportunity: Growing antimicrobial resistance is a serious public health threat requiring new and improved testing methodologies. The market presents opportunities to develop automated, easy-to-use platforms that provide comprehensive, standardized antibiotic sensitivity results more rapidly. Mobile applications and telehealth provide opportunities to decentralize testing and make results more accessible to underserved populations globally.

Threats: Budget constraints in healthcare systems threaten funding availability for new diagnostic tests and technologies. Lower reimbursement rates also reduce returns on investments in research and development. Stringent regulatory requirements lengthen product development timelines and increase costs.

Key Takeaways

Global Antimicrobial Susceptibility Testing Market Size is expected to witness high growth over the forecast period of 2023 to 2030 on account of growing antimicrobial resistance and need for timely identification of effective antibiotics. The market size is projected to reach US$ 3751.4 Mn by 2024, registering a CAGR of 7.9% during the forecast period.

Regional analysis related content comprises
The North America region currently dominates the Antimicrobial Susceptibility Testing market owing to rising prevalence of hospital acquired infections, technological advancements, and presence of leading market players. Asia Pacific region is expected to witness fastest growth over the forecast period supported by growing healthcare investments, increasing awareness regarding AMR, and expansion of healthcare infrastructure in countries like China and India.

Key players related content comprises
Key players operating in the Antimicrobial Susceptibility Testing market are Thermo Fisher Scientific Inc., Cytiva, Sartorius AG, bioMerieux SA, Beckman Coulter Inc., Creative Diagnostics, Danaher Corporation, Alifax Holding S.p.A., and Becton, Dickinson and Company. The market sees continuous new product launches by these established players to consolidate their position through integrated systems and automation.

Explore More Related Article On This Topic: https://www.newsanalyticspro.com/antimicrobial-susceptibility-testing-market-demand/

Explore More Related Article On This Topic: https://allmeaninginhindi.com/understanding-biopharmaceuticals-the-future-of-healthcare-industry/